NovaGo Therapeutics AG
- Biotech or pharma, therapeutic R&D
NovaGo Therapeutics is a Swiss biotech company focused on developing innovative, disease-modifying fully human antibody therapeutics for the treatment of diabetic retinopathy and acute spinal cord injury. We are currently advancing the clinical development of NG004 for spinal cord injury (Phase Ib) and are in the final stages of preparing an Investigational New Drug (IND) application for NG050 in diabetic retinopathy.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}